Intraperitoneal cefoperazone treatment resulting in coagulation abnormality.
Burgess
E
E
Department of Medicine, University of Calgary, Alberta, Canada.
D000328:Adult; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D002438:Cefoperazone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology
D002438:Cefoperazone